Diabetes Management & Weight Loss
Promotes weight loss by activating receptors in the brain to reduce appetite and altering food reward pathways to decrease cravings for high-calorie foods.
Slows down gastric emptying which contributes to prolonged feelings of fullness and reduced overall food intake, which supports weight loss.
They enhance insulin secretion and inhibit glucagon release. These actions lead to improved glycemic control, which supports weight loss by improving metabolic health.
Improve insulin sensitivity by enhancing glucose uptake and glycogen synthesis in peripheral tissues.
Administered as a once weekly injection
Reduce risk of cardiovascular disease, Non-alcoholic fatty liver disease and cognitive decline,
An analog of the human glucagon-like peptide-1 (GLP-1) receptor agonist. It binds to and activates the GLP-1 receptor
Diabetes management and weight loss
Promotes weight loss by activating receptors in the brain to reduce appetite and altering food reward pathways to decrease cravings for high-calorie foods.
Slows down gastric emptying which contributes to prolonged feelings of fullness and reduced overall food intake, which supports weight loss.
They enhance insulin secretion and inhibit glucagon release. These actions lead to improved glycemic control, which supports weight loss by improving metabolic health.
Improve insulin sensitivity by enhancing glucose uptake and glycogen synthesis in peripheral tissues.
Administered as a once weekly injection
Reduce risk of cardiovascular disease, Non-alcoholic fatty liver disease and cognitive decline,
A dual agonist for both the glucose dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors
Diabetes management and weight loss
Promotes weight loss by activating receptors in the brain to reduce appetite and altering food reward pathways to decrease cravings for high-calorie foods.
Slows down gastric emptying which contributes to prolonged feelings of fullness and reduced overall food intake, which supports weight loss.
They enhance insulin secretion and inhibit glucagon release. These actions lead to improved glycemic control, which supports weight loss by improving metabolic health.
Improve insulin sensitivity by enhancing glucose uptake and glycogen synthesis in peripheral tissues.
Administered as a once weekly injection
Reduce risk of cardiovascular disease, Non-alcoholic fatty liver disease and cognitive decline,
A triple hormone receptor agonist. It targets the glucose dependent insulinotropic polypeptide (GIP) receptor, the glucagon-like peptide-1 (GLP-1) receptor & the glucagon receptor.
Follow us on social media